Nucleic acid vaccine - Binhui Biopharmaceutical
Alternative Names: Nucleic acid drug - Binhui BiopharmaceuticalLatest Information Update: 12 Jul 2022
At a glance
- Originator Binhui Biopharmaceutical
- Class Cancer vaccines; DNA vaccines; RNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Cancer; Infections
Most Recent Events
- 20 Jun 2022 Preclinical trials in Cancer in China (Parenteral) (Wuhan Binhui Biotechnology pipeline, June 2022)
- 20 Jun 2022 Preclinical trials in Infections in China (Parenteral) (Wuhan Binhui Biotechnology pipeline, June 2022)